Cargando…
Optimisation of scan duration and image quality in oncological (89)Zr immunoPET imaging using the Biograph Vision PET/CT
PURPOSE: Monoclonal antibody (mAb)-based PET (immunoPET) imaging can characterise tumour lesions non-invasively. It may be a valuable tool to determine which patients may benefit from treatment with a specific monoclonal antibody (mAb) and evaluate treatment response. For (89)Zr immunoPET imaging, h...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10250429/ https://www.ncbi.nlm.nih.gov/pubmed/36947185 http://dx.doi.org/10.1007/s00259-023-06194-4 |
_version_ | 1785055752758493184 |
---|---|
author | van Sluis, Joyce Boellaard, Ronald Dierckx, Rudi A. J. O. van Esch, Evelien L. M. Croes, Demi A. de Ruijter, Laura Kist van de Donk, Pim P. de Vries, Elisabeth G. E. Noordzij, Walter Brouwers, Adrienne H. |
author_facet | van Sluis, Joyce Boellaard, Ronald Dierckx, Rudi A. J. O. van Esch, Evelien L. M. Croes, Demi A. de Ruijter, Laura Kist van de Donk, Pim P. de Vries, Elisabeth G. E. Noordzij, Walter Brouwers, Adrienne H. |
author_sort | van Sluis, Joyce |
collection | PubMed |
description | PURPOSE: Monoclonal antibody (mAb)-based PET (immunoPET) imaging can characterise tumour lesions non-invasively. It may be a valuable tool to determine which patients may benefit from treatment with a specific monoclonal antibody (mAb) and evaluate treatment response. For (89)Zr immunoPET imaging, higher sensitivity of state-of-the art PET/CT systems equipped with silicon photomultiplier (SiPM)-based detector elements may be beneficial as the low positron abundance of (89)Zr causes a low signal-to-noise level. Moreover, the long physical half-life limits the amount of activity that can be administered to the patients leading to poor image quality even when using long scan durations. Here, we investigated the difference in semiquantitative performance between the PMT-based Biograph mCT, our clinical reference system, and the SiPM-based Biograph Vision PET/CT in (89)Zr immunoPET imaging. Furthermore, the effects of scan duration reduction using the Vision on semiquantitative imaging parameters and its influence on image quality assessment were evaluated. METHODS: Data were acquired on day 4 post 37 MBq (89)Zr-labelled mAb injection. Five patients underwent a double scan protocol on both systems. Ten patients were scanned only on the Vision. For PET image reconstruction, three protocols were used, i.e. one camera-dependent protocol and European Association of Nuclear Medicine Research Limited (EARL) standards 1 and 2 compliant protocols. Vision data were acquired in listmode and were reprocessed to obtain images at shorter scan durations. Semiquantitative PET image parameters were derived from tumour lesions and healthy tissues to assess differences between systems and scan durations. Differently reconstructed images obtained using the Vision were visually scored regarding image quality by two nuclear medicine physicians. RESULTS: When images were reconstructed using 100% acquisition time on both systems following EARL standard 1 compliant reconstruction protocols, results regarding semiquantification were comparable. For Vision data, reconstructed images that conform to EARL1 standards still resulted in comparable semiquantification at shorter scan durations (75% and 50%) regarding 100% acquisition time. CONCLUSION: Scan duration of (89)Zr immunoPET imaging using the Vision can be decreased up to 50% compared with using the mCT while maintaining image quality using the EARL1 compliant reconstruction protocol. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00259-023-06194-4. |
format | Online Article Text |
id | pubmed-10250429 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-102504292023-06-10 Optimisation of scan duration and image quality in oncological (89)Zr immunoPET imaging using the Biograph Vision PET/CT van Sluis, Joyce Boellaard, Ronald Dierckx, Rudi A. J. O. van Esch, Evelien L. M. Croes, Demi A. de Ruijter, Laura Kist van de Donk, Pim P. de Vries, Elisabeth G. E. Noordzij, Walter Brouwers, Adrienne H. Eur J Nucl Med Mol Imaging Original Article PURPOSE: Monoclonal antibody (mAb)-based PET (immunoPET) imaging can characterise tumour lesions non-invasively. It may be a valuable tool to determine which patients may benefit from treatment with a specific monoclonal antibody (mAb) and evaluate treatment response. For (89)Zr immunoPET imaging, higher sensitivity of state-of-the art PET/CT systems equipped with silicon photomultiplier (SiPM)-based detector elements may be beneficial as the low positron abundance of (89)Zr causes a low signal-to-noise level. Moreover, the long physical half-life limits the amount of activity that can be administered to the patients leading to poor image quality even when using long scan durations. Here, we investigated the difference in semiquantitative performance between the PMT-based Biograph mCT, our clinical reference system, and the SiPM-based Biograph Vision PET/CT in (89)Zr immunoPET imaging. Furthermore, the effects of scan duration reduction using the Vision on semiquantitative imaging parameters and its influence on image quality assessment were evaluated. METHODS: Data were acquired on day 4 post 37 MBq (89)Zr-labelled mAb injection. Five patients underwent a double scan protocol on both systems. Ten patients were scanned only on the Vision. For PET image reconstruction, three protocols were used, i.e. one camera-dependent protocol and European Association of Nuclear Medicine Research Limited (EARL) standards 1 and 2 compliant protocols. Vision data were acquired in listmode and were reprocessed to obtain images at shorter scan durations. Semiquantitative PET image parameters were derived from tumour lesions and healthy tissues to assess differences between systems and scan durations. Differently reconstructed images obtained using the Vision were visually scored regarding image quality by two nuclear medicine physicians. RESULTS: When images were reconstructed using 100% acquisition time on both systems following EARL standard 1 compliant reconstruction protocols, results regarding semiquantification were comparable. For Vision data, reconstructed images that conform to EARL1 standards still resulted in comparable semiquantification at shorter scan durations (75% and 50%) regarding 100% acquisition time. CONCLUSION: Scan duration of (89)Zr immunoPET imaging using the Vision can be decreased up to 50% compared with using the mCT while maintaining image quality using the EARL1 compliant reconstruction protocol. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00259-023-06194-4. Springer Berlin Heidelberg 2023-03-22 2023 /pmc/articles/PMC10250429/ /pubmed/36947185 http://dx.doi.org/10.1007/s00259-023-06194-4 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Original Article van Sluis, Joyce Boellaard, Ronald Dierckx, Rudi A. J. O. van Esch, Evelien L. M. Croes, Demi A. de Ruijter, Laura Kist van de Donk, Pim P. de Vries, Elisabeth G. E. Noordzij, Walter Brouwers, Adrienne H. Optimisation of scan duration and image quality in oncological (89)Zr immunoPET imaging using the Biograph Vision PET/CT |
title | Optimisation of scan duration and image quality in oncological (89)Zr immunoPET imaging using the Biograph Vision PET/CT |
title_full | Optimisation of scan duration and image quality in oncological (89)Zr immunoPET imaging using the Biograph Vision PET/CT |
title_fullStr | Optimisation of scan duration and image quality in oncological (89)Zr immunoPET imaging using the Biograph Vision PET/CT |
title_full_unstemmed | Optimisation of scan duration and image quality in oncological (89)Zr immunoPET imaging using the Biograph Vision PET/CT |
title_short | Optimisation of scan duration and image quality in oncological (89)Zr immunoPET imaging using the Biograph Vision PET/CT |
title_sort | optimisation of scan duration and image quality in oncological (89)zr immunopet imaging using the biograph vision pet/ct |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10250429/ https://www.ncbi.nlm.nih.gov/pubmed/36947185 http://dx.doi.org/10.1007/s00259-023-06194-4 |
work_keys_str_mv | AT vansluisjoyce optimisationofscandurationandimagequalityinoncological89zrimmunopetimagingusingthebiographvisionpetct AT boellaardronald optimisationofscandurationandimagequalityinoncological89zrimmunopetimagingusingthebiographvisionpetct AT dierckxrudiajo optimisationofscandurationandimagequalityinoncological89zrimmunopetimagingusingthebiographvisionpetct AT vaneschevelienlm optimisationofscandurationandimagequalityinoncological89zrimmunopetimagingusingthebiographvisionpetct AT croesdemia optimisationofscandurationandimagequalityinoncological89zrimmunopetimagingusingthebiographvisionpetct AT deruijterlaurakist optimisationofscandurationandimagequalityinoncological89zrimmunopetimagingusingthebiographvisionpetct AT vandedonkpimp optimisationofscandurationandimagequalityinoncological89zrimmunopetimagingusingthebiographvisionpetct AT devrieselisabethge optimisationofscandurationandimagequalityinoncological89zrimmunopetimagingusingthebiographvisionpetct AT noordzijwalter optimisationofscandurationandimagequalityinoncological89zrimmunopetimagingusingthebiographvisionpetct AT brouwersadrienneh optimisationofscandurationandimagequalityinoncological89zrimmunopetimagingusingthebiographvisionpetct |